The technology aims to help clinicians confidently place local anesthetic. Smiths Medical, a medical device manufacturer, has launched its EchoGlo peripheral nerve block portfolio. This addition...
Abbott will complete the U.S. government order for 150 million BinaxNOW COVID-19 tests this week and will supply 30 million additional tests through March via a...
Delfi Diagnostics, a developer of blood tests for early cancer detection, has secured $100m investment in a Series A funding round, led by healthcare-focused investment firm...
Roche Diagnostics India, part of the Roche Group, today announced the appointment of Narendra Varde as Managing Director for India and Neighbouring Markets. Narendra joins Roche...
Snibe Diagnostic said this week that it has received CE marking for its Maglumi SARS-CoV-2 Neutralizing Antibody Assay. According to Snibe, the fully automated test can...
Doctors soon will have a new way to evaluate patients with concussions: a rapid blood test made by Abbott Laboratories that has been cleared by the...
Mid-market private equity firm Stakeboat Capital on Tuesday said it has launched its second fund that seeks to raise Rs 1,000 crore ($136 million). The second...
The Google News Initiative on Tuesday launched a global open fund to fight misinformation about COVID-19 vaccines, worth up to $3 million. The “COVID-19 Vaccine Counter...
BD (Becton Dickinson and Company) has disclosed that it expects total revenue for Q1 2021 to hit $5.3bn. If achieved, the figure would represent a 25.6%...
Quanterix has secured an emergency use authorisation (EUA) from the US Food and Drug Administration (FDA) for its Simoa SARS-CoV-2 N protein antigen test. Simoa (single...
Pfizer Inc’s partner BioNTech SE has boosted the 2021 delivery target for their COVID-19 vaccine to 2 billion doses, up from 1.3 billion previously, as they add new...
Drug firm Boehringer Ingelheim on Monday said it has appointed Vani Manja as country Managing Director for India, effective January 1, 2021. In the role, Vani...
After a three-time no-show before the expert panel on vaccines in India, US major Pfizer, which was one of the first firms to apply for a...
Inari Medical has received the US Food and Drug Administration (FDA) 510(k) approval for its FlowTriever system to treat pulmonary embolism and right atrial clot in...
British medical technology firm Quanta Dialysis Technologies has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its haemodialysis system called SC+. The...
Copyright © 2024 Medical Buyer